NIH BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science

Funding Opportunity Number: RFA-MH-25-171 Deadline: October 11, 2024 Research Objectives One of the defined themes in the BRAIN 2025 report … Continue reading “NIH BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science”

NIH HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03)

Funding Opportunity Number: PAR-24-197 Deadlines: June 16, 2024, July 16, 2024, October 16, 2024, November 16, 2024 Application Budgets: Limited … Continue reading “NIH HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03)”

“Generation of renal specific NAD kinase knockout and transgenic mouse models ” NIH R01

Funding Opportunity Number: PAR-24-203 Deadlines Letter of Intent: September 4, 2024 Submission: October 4, 2024 Objectives The goal of this … Continue reading ““Generation of renal specific NAD kinase knockout and transgenic mouse models ” NIH R01”

NIH BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science

Funding Opportunity Number: RFA-MH-25-171 Deadline: October 11, 2024 Research Objectives One of the defined themes in the BRAIN 2025 report … Continue reading “NIH BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science”

NIH HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03)

Funding Opportunity Number: PAR-24-197 Deadlines: June 16, 2024, July 16, 2024, October 16, 2024, November 16, 2024 Application Budgets: Limited … Continue reading “NIH HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03)”

NIH: Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Amyloid Beta Immunotherapy (R01)

Funding Opportunity Number: PAR-24-198 Deadlines: October 4, 2024, November 4, 2024 Description Goal 1 of the National Plan to Address … Continue reading “NIH: Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Amyloid Beta Immunotherapy (R01)”

“Generation of renal specific NAD kinase knockout and transgenic mouse models ” NIH R01

Funding Opportunity Number: PAR-24-203 Deadlines Letter of Intent: September 4, 2024 Submission: October 4, 2024 Objectives The goal of this … Continue reading ““Generation of renal specific NAD kinase knockout and transgenic mouse models ” NIH R01”